NCT03676400

Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

Clinical Study for the Assessment of the Hair Growth Efficacy and Safety of a Cosmetic Investigational Product, After Repeated Applications for 24 Weeks, Under Normal Conditions of Use, in the Asian Adult Subjects With Androgenic Alopecia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 84 (actual)
• Sponsor: Medipost Co Ltd. · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess whether cosmetic investigational product containing NGF-574H is safe and effective in the treatment of androgenic alopecia in asian adults.

Detailed description

NGF-574H is a obtained by collection of paracrine factors secreted by human umbilical cord blood-derived mesenchymal stem cell that was exposed in vitro to an artificially designed environment mimicking alopecia state in hair follicles to prime the composition of the paracrine factors optimized for hair growth. This study is to assess and confirm whether NGF-574H is safe and effective in the treatment of androgenic alopecia in asian adults.

Conditions

• Androgenic Alopecia

Interventions

Type	Name	Description
OTHER	conditioned media of umbilical cord blood-derived stem cells	Hair serum with 5% conditioned media of human umbilical cord blood-derived mesenchymal stem cells
OTHER	Placebo	Hair serum without conditioned media of human umbilical cord blood-derived mesenchymal stem cells

Timeline

• Start date: 2018-10-02
• Primary completion: 2019-07-22
• Completion: 2019-07-24
• First posted: 2018-09-18
• Last updated: 2019-08-12

Locations

1 site across 1 country: South Korea